Home
Management Team
Clinical Advisors
Contact

NXDC

Home
Management Team
Clinical Advisors
Contact
June 7, 2017
Kerry Geary
NXDC receives US FDA approval for Gleolan ...

NXDC announced today that the U.S. Food and Drug Administration approved aminolevulinic acid hydrochloride, known as ALA HCl (Gleolan) as an optical imaging agent indicated in patients with gliomas (suspected World Health Organization Grades III or IV on preoperative imaging) as an adjunct for the visualization of malignant tissue during surgery.

NXDC receives US FDA approval for Gleolan (Aminolevulinic acid hydrochloride, known as ALA HCl)
Kerry Geary
June 7, 2017

NXDC receives US FDA approval for Gleolan (Aminolevulinic acid hydrochloride, known as ALA HCl)

Kerry Geary
June 7, 2017
NXDC receives US FDA approval for Gleolan (Aminolevulinic acid hydrochloride, known as ALA HCl)

NXDC announced today that the U.S. Food and Drug Administration approved aminolevulinic acid hydrochloride, known as ALA HCl (Gleolan) as an optical imaging agent indicated in patients with gliomas (suspected World Health Organization Grades III or IV on preoperative imaging) as an adjunct for the visualization of malignant tissue during surgery.

Back to Top
870 Corporate Drive, Suite 403, Lexington, KY 40503, USA(305) 929-3125info@nxdevcorp.com